Drugs / Infanrix IPV/Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00345358 Comparator | Sep 2006 → Nov 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00345358 ↗ |
| Modality | Vaccine | “Children below 6 months of age will receive concomitantly a DTPa-IPV/Hib vaccine.” NCT00345358 ↗ |
| Route | Intramuscular | “4 intramuscular injections” NCT00345358 ↗ |